YAMASHITA HEALTH CARE HOLDINGS, INC.(JP:9265)
Â¥3,350.00-85.00 (-2.47%)
JP:9265
YAMASHITA HEALTH CARE HOLDINGS, INC. financials statements
Â¥3,350.00
At close:-85.00 (-2.47%)
Want to see JP:9265 full AI Analyst Report?
YAMASHITA HEALTH CARE HOLDINGS, INC. (9265) Ratios
0 Followers
YAMASHITA HEALTH CARE HOLDINGS, INC. Ratios
JP:9265's free cash flow for Q4 2025 was ¥-1.20B. For the 2025 fiscal year, JP:9265's free cash flow was decreased by ¥-1.29B and operating cash flow was ¥88.00M. See a summary of the company’s cash flow.
| Ratios | May 25 | May 24 | May 23 | May 22 | May 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.18 | 1.20 | 1.19 | 1.21 | 1.21 |
| Quick Ratio | 0.97 | 1.03 | 1.02 | 1.03 | 1.03 |
| Cash Ratio | 0.24 | 0.32 | 0.30 | 0.36 | 0.26 |
| Solvency Ratio | 0.05 | 0.05 | 0.04 | 0.03 | 0.06 |
| Operating Cash Flow Ratio | 0.01 | 0.03 | 0.05 | 0.13 | 0.04 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ¥ 2.77B | ¥ 3.21B | ¥ 2.89B | ¥ 2.87B | ¥ 2.71B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.89 | 3.07 | 3.11 | 3.11 | 3.02 |
| Debt Service Coverage Ratio | 126.33 | 122.50 | 0.00 | 208.50 | 305.70 |
| Interest Coverage Ratio | 130.00 | 139.83 | 0.00 | 578.00 | 310.25 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.39 | 2.43 | 0.00 | 0.78 | 1.18 |
| Net Debt to EBITDA | -3.97 | -5.36 | -4.88 | -6.93 | -3.19 |
| Profitability Margins | |||||
| Gross Profit Margin | 13.34% | 13.29% | 13.81% | 13.83% | 14.01% |
| EBIT Margin | 1.22% | 1.30% | 1.42% | 1.09% | 1.86% |
| EBITDA Margin | 1.62% | 1.65% | 1.76% | 1.44% | 2.26% |
| Operating Profit Margin | 1.22% | 1.30% | 1.57% | 1.99% | 1.69% |
| Pretax Profit Margin | 1.45% | 1.46% | 1.41% | 1.09% | 1.86% |
| Net Profit Margin | 1.01% | 0.96% | 0.94% | 0.38% | 1.26% |
| Continuous Operations Profit Margin | 1.01% | 0.95% | 0.94% | 0.36% | 1.26% |
| Net Income Per EBT | 69.75% | 65.32% | 66.59% | 34.49% | 67.87% |
| EBT Per EBIT | 119.10% | 112.40% | 89.98% | 54.93% | 110.18% |
| Return on Assets (ROA) | 2.39% | 2.24% | 2.18% | 0.89% | 2.89% |
| Return on Equity (ROE) | 6.92% | 6.86% | 6.79% | 2.77% | 8.72% |
| Return on Capital Employed (ROCE) | 7.99% | 8.87% | 10.79% | 13.71% | 10.91% |
| Return on Invested Capital (ROIC) | 5.56% | 5.77% | 7.16% | 4.58% | 7.40% |
| Return on Tangible Assets | 2.42% | 2.27% | 2.21% | 0.90% | 2.91% |
| Earnings Yield | 8.34% | 9.60% | 8.53% | 4.28% | 14.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.32 | 5.29 | 5.31 | 5.55 | 4.64 |
| Payables Turnover | 3.49 | 3.42 | 6.41 | 3.46 | 3.44 |
| Inventory Turnover | 15.29 | 17.37 | 17.69 | 17.19 | 17.48 |
| Fixed Asset Turnover | 14.75 | 19.09 | 19.56 | 17.50 | 15.92 |
| Asset Turnover | 2.37 | 2.34 | 2.32 | 2.37 | 2.29 |
| Working Capital Turnover Ratio | 18.73 | 18.47 | 18.43 | 17.60 | 18.46 |
| Cash Conversion Cycle | -12.15 | -16.74 | 32.41 | -18.44 | -6.45 |
| Days of Sales Outstanding | 68.63 | 68.97 | 68.74 | 65.71 | 78.69 |
| Days of Inventory Outstanding | 23.88 | 21.01 | 20.64 | 21.24 | 20.88 |
| Days of Payables Outstanding | 104.66 | 106.72 | 56.98 | 105.39 | 106.02 |
| Operating Cycle | 92.51 | 89.99 | 89.38 | 86.95 | 99.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 35.10 | 249.87 | 344.88 | 848.45 | 227.69 |
| Free Cash Flow Per Share | -479.88 | 136.88 | 314.64 | 816.72 | 181.25 |
| Dividend Paid and CapEx Coverage Ratio | 0.06 | 1.36 | 4.41 | 7.47 | 1.67 |
| Capital Expenditure Coverage Ratio | 0.07 | 2.21 | 11.40 | 26.74 | 4.90 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.01 | 0.01 | 0.04 | 0.01 |
| Free Cash Flow Yield | -15.48% | 5.27% | 11.78% | 40.73% | 9.36% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 11.99 | 10.42 | 11.72 | 23.37 | 7.10 |
| Price-to-Sales (P/S) Ratio | 0.12 | 0.10 | 0.11 | 0.09 | 0.09 |
| Price-to-Book (P/B) Ratio | 0.83 | 0.71 | 0.80 | 0.65 | 0.62 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.46 | 18.99 | 8.49 | 2.45 | 10.69 |
| Price-to-Operating Cash Flow Ratio | 88.31 | 10.40 | 7.74 | 2.36 | 8.51 |
| Price-to-Earnings Growth (PEG) Ratio | 3.32 | 1.10 | 0.07 | -0.34 | 2.74 |
| Enterprise Value Multiple | 3.50 | 0.68 | 1.38 | -0.84 | 0.78 |
| Enterprise Value | 3.64B | 719.65M | 1.50B | -706.46M | 969.20M |
| EV to EBITDA | 3.50 | 0.68 | 1.38 | -0.84 | 0.78 |
| EV to Sales | 0.06 | 0.01 | 0.02 | -0.01 | 0.02 |
| EV to Free Cash Flow | -3.03 | 2.13 | 1.87 | -0.34 | 2.09 |
| EV to Operating Cash Flow | 41.41 | 1.17 | 1.71 | -0.33 | 1.67 |
| Tangible Book Value Per Share | 3604.08 | 3489.28 | 3228.07 | 3060.07 | 3080.68 |
| Shareholders’ Equity Per Share | 3733.72 | 3635.48 | 3355.34 | 3096.89 | 3126.18 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.30 | 0.35 | 0.34 | 0.67 | 0.32 |
| Revenue Per Share | 25589.15 | 26115.36 | 24179.12 | 22795.77 | 21601.37 |
| Net Income Per Share | 258.49 | 249.47 | 227.83 | 85.79 | 272.63 |
| Tax Burden | 0.70 | 0.65 | 0.67 | 0.34 | 0.68 |
| Interest Burden | 1.19 | 1.12 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.12 | 0.12 | 0.11 | 0.11 | 0.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.14 | 1.00 | 1.51 | 3.41 | 0.57 |
Currency in JPY

